Granite Harbor Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406K Sell
4,488
-29
-0.6% -$2.43K 0.16% 92
2026
Q1
$362K Sell
4,517
-304
-6% -$25.1K 0.16% 91
2025
Q4
$411K Buy
4,821
+97
+2% +$7.96K 0.17% 83
2025
Q3
$367K Sell
4,724
-24
-0.5% -$1.88K 0.15% 94
2025
Q2
$371K Sell
4,748
-241
-5% -$18K 0.17% 84
2025
Q1
$362K Buy
4,989
+462
+10% +$33.1K 0.19% 75
2024
Q4
$335K Buy
4,527
+57
+1% +$3.99K 0.19% 69
2024
Q3
$295K Buy
4,470
+463
+12% +$33.6K 0.17% 76
2024
Q2
$370K Buy
4,007
+185
+5% +$16.4K 0.23% 68
2024
Q1
$365K Buy
3,822
+32
+0.8% +$2.69K 0.25% 62
2023
Q4
$289K Sell
3,790
-42
-1% -$2.92K 0.22% 65
2023
Q3
$265K Buy
3,832
+155
+4% +$12.5K 0.21% 67
2023
Q2
$347K Buy
3,677
+181
+5% +$15.7K 0.27% 56
2023
Q1
$289K Sell
3,496
-7
-0.2% -$550 0.26% 59
2022
Q4
$261K Buy
+3,503
New +$270K 0.27% 56

Other funds holding EW

Granite Harbor Advisors's EW Position: Q2 2026 in Review

Granite Harbor Advisors reduced its Edwards Lifesciences (EW) stake by 0.64% in Q2 2026, selling an estimated $2.43K and leaving 4,488 shares worth $406K. The position accounts for 0.16% of the portfolio, ranked #92.

Granite Harbor Advisors first reported a position in EW in Q4 2022 and has held it in 15 quarters since. The position peaked at $411K in Q4 2025. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Granite Harbor Advisors held 4,488 shares of Edwards Lifesciences worth $406K as of Q2 2026.
  • Granite Harbor Advisors sold 29 Edwards Lifesciences shares in Q2 2026, an estimated $2.43K.
  • Edwards Lifesciences made up 0.16% of Granite Harbor Advisors's portfolio in Q2 2026, its #92 holding.
  • Granite Harbor Advisors first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 15 quarters since.
  • Granite Harbor Advisors's Edwards Lifesciences position peaked at $411K in Q4 2025.
  • 563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Granite Harbor Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.